調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Stem Cell Banking Market by Bank Type (Cord Blood, and Cord Tissue), Service (Collection & Transportation, Analysis, Processing, and Storage), Application (Cerebral Palsy, Leukemia, Thalassemia, Anemia, Autism, Diabetes), Region - Forecast to 2021

幹細胞バンクの世界市場：臍帯血バンク、コード組織バンク

◆タイトル：Stem Cell Banking Market by Bank Type (Cord Blood, and Cord Tissue), Service (Collection & Transportation, Analysis, Processing, and Storage), Application (Cerebral Palsy, Leukemia, Thalassemia, Anemia, Autism, Diabetes), Region - Forecast to 2021
◆商品コード：BT-4447
◆調査・発行会社：MarketsandMarkets
◆発行日：2016年7月18日
◆ページ数：121
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオ技術
◆販売価格オプション（消費税別）
Single UserUSD5,650 ⇒換算￥615,850見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥724,850見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥888,350見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

当調査レポートでは、幹細胞バンクの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、バンク種類別分析、サービス別分析、用途別分析、地域別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global stem cell banking market is expected to reach USD 3.96 Billion by 2021 from USD 1.58 Billion in 2016, at a CAGR of 20.2% from 2016 to 2021. Increasing awareness regarding the storage of cord blood and tissue stem cells, high growth potential of emerging economies, and increasing use of stem cells in the field of therapeutics have opened an array of opportunities for the growth of the market in the coming years.
The global stem cell banking market is classified on the basis of type into cord blood and cord blood & cord tissue. On the basis of services, the market is segmented into collection & transportation, processing, analysis, and storage. The major applications of stem cell banking include cerebral palsy, leukemia, thalassemia, anemia, autism, diabetes, and others. Among these applications, stem cells are mainly used for the treatment of cerebral palsy.

The storage services segment is estimated to command the largest share in 2016 and the forecast period. North America is the major market for this segment. The high share of the storage services segment can be attributed to the high cost of the equipment required for the storage of cord blood and cord tissue, in turn increasing the per-year cost of maintenance of the sample units.

By region, the report segments the stem cell banking market into four regions–North America, Europe, Asia-pacific, and the Rest of the World. Among these regions, North America holds the largest market share. This is attributed to factors such as availability of federal funding for stem cell research. In addition, the preference for private banks has risen in the U.S.; in 2013, 2.6% of parents were opting for private banks as opposed to 0.4% in 2004. Moreover, an FDA-approved clinical trial showed that the use of stem cells helped improve impaired sight in 2014 and provide the safety of stem cell therapy in the long run.

A key restraint to market growth is the high cost of storage. The approximate cost incurred in storing cells for 25 years is USD 1,500 with a USD 150 per-year maintenance charge. In addition, the cost of cell therapies to treat diseases is high, with no guaranteed success due to the variability of the samples even after standardization checks. Based on a company’s operating facilities, the cost of processing and storage of samples might further increase.

The major players operating in the stem cell banking market include StemCyte (U.S.), Cryo-Cell International (U.S.), ViaCord (By Perkin Elmer) (U.S.), Cord Blood Registry (U.S.), Smart Cells (U.K.), Cryo-Save (Europe), Cryoviva (India), LifeCell (India), Cordlife (Singapore), Cordvida (Brazil), and China Cord Blood Corporation (China).

Cord Blood Registry, San Bruno, (U.S.) accounted for the largest share of the stem cell banking market in 2015. It is the largest bank for the storage of umbilical cord blood and cord blood tissue, with more than 600,000 units stored till date.

【レポートの目次】

1 Introduction (Page No. – 12)
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 15)
2.1 Research Data
2.1.1 Key Data From Secondary Sources
2.1.2 Key Data From Primary Sources
2.1.2.1 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
2.4.1 Assumptions

3 Executive Summary (Page No. – 23)

4 Premium Insights (Page No. – 25)
4.1 Attractive Opportunities in the Stem Cell Banking Market

5 Market Overview (Page No. – 28)
5.1 Market Segmentation
5.1.1 Stem Cell Banking, By Bank Type
5.1.2 Stem Cell Banking, By Service
5.1.3 Stem Cell Banking, By Application
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Easy Extraction Methods
5.2.1.2 Rising Number of Newborns
5.2.1.3 Growth in Gdp, Disposable Income, and Increased Awareness of Stem Cell Therapeutics
5.2.1.4 Potential of Stem Cells in Disease Treatment
5.2.2 Restraints
5.2.2.1 High Competition in the Stem Cell Banking Market
5.2.2.2 High Operating Cost
5.2.2.3 Lack of Acceptance
5.2.2.4 Changes in Legal Regulations
5.2.3 Opportunities
5.2.3.1 Rising Awareness About Potential Use of Cord Tissue
5.2.3.2 Collaborations Among Cord Blood Banks
5.2.3.3 The Automation of Procedures
5.2.4 Challenges
5.2.4.1 Entry Barriers in the Market

6 Stem Cell Banking Market, By Bank Type (Page No. – 34)
6.1 Introduction
6.2 Cord Blood
6.3 Cord Tissue

7 Stem Cell Banking Market, By Service (Page No. – 43)
7.1 Introduction
7.2 Collection & Transportation
7.3 Processing
7.4 Analysis
7.5 Storage

8 Stem Cell Banking Market, By Application (Page No. – 52)
8.1 Introduction
8.2 Cerebral Palsy
8.3 Thalassemia
8.4 Leukemia
8.5 Diabetes
8.6 Autism
8.7 Others

9 Stem Cell Banking Market, By Region (Page No. – 67)
9.1 Introduction
9.2 North America
9.2.1 North America, By Country
9.2.2 North America, By Type
9.2.3 North America, By Service
9.2.4 North America, By Application
9.3 Europe
9.3.1 Europe, By Country
9.3.2 Europe, By Type
9.3.3 Europe, By Service
9.3.4 Europe, By Application
9.4 Asia-Pacific
9.4.1 Asia-Pacific, By Country
9.4.2 Asia-Pacific, By Type
9.4.3 Asia-Pacific, By Service
9.4.4 Asia-Pacific, By Application
9.5 Rest of The World (RoW)
9.5.1 Rest of the World, By Type
9.5.2 Rest of the World, By Service
9.5.3 Rest of the World, By Application

10 Competitive Landscape (Page No. – 85)
10.1 Company Share Analysis
10.2 New Service/Product Launches
10.3 Mergers & Acquisitions
10.4 Regulatory Approvals
10.5 Partnerships
10.6 Joint Venture
10.7 Agreements
10.8 Collaborations
10.9 Technological Update
10.10 Patent
10.11 Geographical Expansion
10.12 Others

11 Company Profile (Page No. – 91)
(Company at A Glance, Business Overview, Products Offered, Key Strategy, Recent Developments, SWOT Analysis & MnM View)*
11.1 CBR Systems, Inc.
11.2 Cordlife
11.3 Cryo-Cell
11.4 Cryo-Save AG (A Group of Esperite)
11.5 Lifecell
11.6 Stemcyte
11.7 Viacord
11.8 Smart Cells International Ltd.
11.9 Cryoviva India
11.10 Cordvida
11.11 China Cord Blood Corporation

*Details on Company at A Glance, Recent Financials, Products Offered, Strategies & Insights, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 112)
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports

List of Tables (62 Tables)

Table 1 Global Stem Cell Banking Market, By Bank Type, 2014-2021 (Units)
Table 2 Market Volume, By Bank Type, 2016 (%)
Table 3 Market, By Bank Type, 2014-2021 (USD Million)
Table 4 Market Value, By Bank Type, 2016 (%)
Table 5 Cord Blood Stem Cell Banking Market, By Region, 2014-2021 (Units)
Table 6 Cord Blood Stem Cell Banking Market Volume, By Region, 2016 (%)
Table 7 Cord Blood Stem Cell Banking Market, By Region, 2014-2021 (USD Million)
Table 8 Cord Blood Stem Cell Banking Market Value, By Region, 2016 (%)
Table 9 Global Cord Blood & Cord Tissue Stem Cell Banking Market, By Region, 2014-2021 (Units)
Table 10 Cord Blood & Cord Tissue Stem Cell Banking Market Volume, By Region, 2016 (%)
Table 11 Global Cord Blood & Cord Tissue Stem Cell Banking Market, By Region, 2014-2021 (USD Million)
Table 12 Cord Blood & Cord Tissue Stem Cell Banking Market Value, By Region, 2016 (%)
Table 13 Market, By Services, 2014-2021 (USD Million)
Table 14 Market Value, By Services, 2016 & 2021 (%)
Table 15 Market for Collection & Transportation, By Region, 2014-2021 (USD Million)
Table 16 Market for Processing, By Region, 2014-2021 (USD Million)
Table 17 Market for Analysis, By Region, 2014-2021 (USD Million)
Table 18 Market for Storage, By Region, 2014-2021 (USD Million)
Table 19 Number of Samples Used for Application, 2014-2021 (Units)
Table 20 Market, By Application, 2014-2021 (Units)
Table 21 Market, By Application, 2014-2021 (%)
Table 22 Number of Stem Cell Units Released for Application Market, By Region, 2014-2021 (Units)
Table 23 Number of Clinical Trials Using Stem Cells From Cord Blood and Cord Tissue in Cerebral Palsy Treatment From 2014-2016
Table 24 Market in Cerebral Palsy, By Region, 2014-2021 (Units)
Table 25 Market in Thalassemia, By Region, 2014-2021 (Units)
Table 26 Market in Leukemia, By Region, 2014-2021 (Units)
Table 27 Market in Anemia, By Region, 2014-2021 (Units)
Table 28 Market in Diabetes, By Region, 2014-2021 (Units)
Table 29 Market in Autism, By Region, 2014-2021 (Units)
Table 30 Market in Others, By Region, 2014-2021 (Units)
Table 31 Market, Overview, 2014-2021
Table 32 Market, By Region, 2014-2021 (Units)
Table 33 Market Volume, By Region, 2014-2021 (%)
Table 34 Market, By Region, 2014-2021 (USD Million)
Table 35 Market Value, By Region, 2014-2021 (%)
Table 36 North America Market, By Country, 2014-2021 (Units)
Table 37 North America Market, By Country, 2014-2021 (USD Million)
Table 38 North America Market, By Type, 2014-2021 (Units)
Table 39 North America Market, By Type, 2014-2021 (USD Million)
Table 40 North America Market, By Service, 2014 -2021 (USD Million)
Table 41 North America Market, Usage, 2014-2021
Table 42 North America Market, By Application, 2014-2021 (Units)
Table 43 Europe Market, By Country, 2014-2021 (Units)
Table 44 Europe Market, By Country, 2014-2021 (USD Million)
Table 45 Europe Market, By Type, 2014-2021 (Units)
Table 46 Europe Market, By Type, 2014-2021 (USD Million)
Table 47 Europe Market, By Service, 2014 -2021 (USD Million)
Table 48 Europe Market, Usage, 2014-2021
Table 49 Europe Market, By Application, 2014-2021 (Units)
Table 50 Asia-Pacific Market, By Country, 2014-2021 (Units)
Table 51 Asia-Pacific Market, By Country, 2014-2021 (USD Million)
Table 52 Asia-Pacific Market, By Type, 2014-2021 (Units)
Table 53 Asia-Pacific Market, By Type, 2014-2021 (USD Million)
Table 54 Asia-Pacific Market, By Service, 2014 -2021 (USD Million)
Table 55 Asia-Pacific Market, Usage, 2014-2021
Table 56 Asia-Pacific Market, By Application, 2014-2021 (Units)
Table 57 Rest of the World Market, By Type, 2014-2021 (Units)
Table 58 Rest of the World Market, By Type, 2014-2021 (USD Million)
Table 59 Rest of the World Market, By Service, 2014 -2021 (USD Million)
Table 60 Rest of the World Market, Usage, 2014-2021
Table 61 Rest of the World Market, By Application, 2014-2021 (Units)
Table 62 Market: Company Share Analysis, 2015 (%)

List of Figures (40 Figures)

Figure 1 Market: Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation,& Region
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Global Market to Witness High Growth During the Forecast Period
Figure 6 The Processing Services Segment Expected to Lead the Market in 2016
Figure 7 Asia-Pacific to Witness the Highest Growth Rate During the Forecast Period
Figure 8 Market, By Bank Type, 2016 & 2021 (Units)
Figure 9 Market, By Bank Type, 2016 & 2021 (USD Million)
Figure 10 Cord Blood Market, By Region, 2016 & 2021 (Units)
Figure 11 Cord Blood Market, By Region, 2016 & 2021 (USD Million)
Figure 12 Cord Blood & Cord Tissue Stem Cell Banking Market, By Region, 2016 & 2021 (Units)
Figure 13 Cord Blood & Cord Tissue Stem Cell Banking Market, By Region, 2016 & 2021 (USD Million)
Figure 14 Market, By Services
Figure 15 Processing Segment Expected to Continue Leading the Market During Forecast Period
Figure 16 Market for Collection & Transportation, By Region, 2016 & 2021 (USD Million)
Figure 17 Processing is Expected to Be the Largest Segment of the North American Market
Figure 18 Market for Analysis, By Region, 2016 & 2021 (USD Million)
Figure 19 Market for Storage, By Region, 2016 & 2021, (USD Million)
Figure 20 Largest Number of Stem Cells are Expected to Be Utilized to Treat Leukemia By 2021 Globally
Figure 21 North America to Continue Leading the Application Segment of the Market During Forecast Period
Figure 22 Cerebral Palsy is Expected to Use the Largest Number of Stem Cell Units in 2016
Figure 23 North America is Estimated to Lead the Market in Thalassemia in 2016
Figure 24 Largest Number of Stem Cells From Cord Blood to Be Consumed for Leukemia Treatment
Figure 25 Stem Cell Banking Market in Anemia, By Region, 2016 & 2021 (Units)
Figure 26 Diabetes is Expected to Be the Fastest Growing Segment of Market During Forecast Period
Figure 27 Stem Cell Banking Market in Autism, By Region, 2016 & 2021 (Units)
Figure 28 Stem Cell Banking Market in Others, By Region, 2016 & 2021 (Units)
Figure 29 Asia-Pacific is Expected to Grow at the Highest CAGR During the Forecast Period
Figure 30 North America Will Continue to Dominate the Stem Cell Banking Market During Forecast Period
Figure 31 North America Stem Cell Banking Market Snapshot
Figure 32 Europe Stem Cell Banking Market Snapshot
Figure 33 Asia-Pacific Stem Cell Banking Market Snapshot
Figure 34 Stem Cell Banking Market: Company Share Analysis, 2015 (%)
Figure 35 CBR Systems, Inc.: Business Overview
Figure 36 Cordlife: Business Overview
Figure 37 Cryo-Cell: Business Overview
Figure 38 Cryo-Save AG (A Group of Esperite): Business Overview
Figure 39 Viacord: Business Overview
Figure 40 China Cord Blood Corporation: Business Overview

【レポートのキーワード】

幹細胞バンク、臍帯血バンク、コード組織バンク、サービス、治療、医療、脳性小児まひ、地中海貧血症

★調査レポート[幹細胞バンクの世界市場：臍帯血バンク、コード組織バンク] ( Stem Cell Banking Market by Bank Type (Cord Blood, and Cord Tissue), Service (Collection & Transportation, Analysis, Processing, and Storage), Application (Cerebral Palsy, Leukemia, Thalassemia, Anemia, Autism, Diabetes), Region - Forecast to 2021 / BT-4447) 販売に関する免責事項
[幹細胞バンクの世界市場：臍帯血バンク、コード組織バンク] ( Stem Cell Banking Market by Bank Type (Cord Blood, and Cord Tissue), Service (Collection & Transportation, Analysis, Processing, and Storage), Application (Cerebral Palsy, Leukemia, Thalassemia, Anemia, Autism, Diabetes), Region - Forecast to 2021 / BT-4447) についてEメールでお問い合わせ
◆関連調査資料◆
  • 幹細胞バンキングの世界市場予測（～2023年）
    BT4447 / MarketsandMarkets / 2018年5月15日 / MarketsandMarketsが発行した当調査レポートでは、幹細胞バンキングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、ソース別分析、サービス種類別分析、用途別分析、地域別分析、幹細胞バンキングの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global stem cell banking market is projected to reach USD 9.30 Billion by 2023 from USD 6.28 Billion in 2018, at a CAGR of 8.2%. Factors such as public awareness related to the therapeutic potential of stem cells; development of novel technologies for stem cell preservation, processing, and storage; rising number of hematopoietic stem cell transplantations (HSCTs); and increasing number of stem cell-based research are driving the growth of the market. This report broadly categorizes the global stem cell banking market into source, application, service type, and region/country. Based on source, the stem cell banking market is segmented into...
  • 幹細胞治療の世界市場予測（～2021年）：同種幹細胞、自己幹細胞
    MAM-BT5049 / MarketsandMarkets / 2017年2月28日 / 当調査レポートでは、幹細胞治療の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、用途別分析、ソース別分析、地域別分析、幹細胞治療の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global stem cell therapy market is estimated to grow at a CAGR of 11.0% during 2016 to 2021 to reach USD 145.8 million by 2021. Growth in the global stem cell therapy market is driven by factors such as the growing awareness of the therapeutic potency of stem cells in effective disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for development of stem cell therapies, identification of new stem cell lines, and developments in infrastructure related to stem cell banking and processing. In addition, countries such as Japan, South Korea, and China are offering new...
  • 幹細胞アッセイの世界市場予測（～2023年）
    MAM-BT-4628 / MarketsandMarkets / 2018年3月28日 / MarketsandMarketsが発行した当調査レポートでは、幹細胞アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、細胞タイプ別分析、製品別分析、用途別分析、幹細胞アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global stem cell assay market is expected to reach USD 1,978.7 Million by 2023 from USD 791.9 Million in 2018, at a CAGR of 20.1%. The market growth is primarily driven by increasing government and private funding for stem cell research and technological innovations in stem cell research-based instruments. The global stem cell assay market is segmented by type, cell type, product & service, application, end user, and region. By type, the market is segmented into viability/cytotoxicity, isolation & purification, cell identification, proliferation, differentiation, function, and apoptosis assays. The viability/cytotoxicity segment accounted for the largest market share of the...
  • 幹細胞製造の世界市場予測（～2023年）：HSC、MSC、iPSC、ESC、装置、培地、消耗品
    BT-6089 / MarketsandMarkets / 2018年3月13日 / MarketsandMarketsが発行した当調査レポートでは、幹細胞製造の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別分析、用途別分析、需要先別分析、地域別分析、幹細胞製造の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global stem cell manufacturing market is projected to reach USD 14.61 Billion by 2023 from USD 10.75 Billion in 2018, at a CAGR of 6.3%. Factors such as growing public-private investments and funding in stem cell-based research, rising public awareness regarding about the therapeutic potency of stem cell products, development of advanced genomic analysis techniques for quality control during stem cell manufacturing, technological advancements in stem cell manufacturing and preservation, and evolving regulatory frameworks for stem cell therapeutics in the US and Europe are driving the growth of the market. This report broadly segments the stem cell manufacturing market...
  • 解凍装置の世界市場予測（～2022年）：種類、サンプル（血、血漿、RBC、血小板、全血、胎芽、精液）、エンドユーザー
    MD-5756 / MarketsandMarkets / 2017年11月23日 / MarketsandMarketsが発行した当調査レポートでは、解凍装置の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、サンプル別分析、需要先別分析、地域別分析、解凍装置の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global thawing system market is expected to reach USD 252.7 Million by 2022 from USD 139.6 Million in 2017, at a CAGR of 12.6%. The market growth is primarily driven by the growing incidence of chronic diseases and technological advancements in thawing devices. The global thawing system market is segmented by type, sample type, end user, and region. By type, the thawing system market is segmented into manual and automated devices. The manual devices segment is estimated to account for the largest market share of the global thawing system market in 2017. Factors driving the growth of this segment...
  • 神経修復・神経再生の世界市場予測（～2022年）
    MAM-MD-3642 / MarketsandMarkets / 2017年11月10日 / MarketsandMarketsが発行した当調査レポートでは、神経修復・神経再生の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、用途別分析、製品別分析、地域別分析、神経修復・神経再生の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The nerve repair and regeneration market is expected to reach USD 10.59 million by 2022 from USD 5.79 billion in 2017, at a CAGR of 12.9%. Factors such as increasing number of neurological disorders, technological advancements, and rising geriatric population are driving the growth of this market. On the other hand, donor-site morbidity, difficulties in treating large nerve gaps, and stringent regulatory frameworks and time-consuming approval processes may challenge the growth of the market.Neurostimulation and neuromodulation devices segment is expected to account for the largest share in the market On the basis of product, the nerve repair and regeneration market...
  • 細胞内シグナル伝達の世界市場予測（～2022年）：内分泌、傍分泌
    MAM-BT5257 / MarketsandMarkets / 2017年5月12日 / 当調査レポートでは、細胞内シグナル伝達の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、細道別分析、製品別分析、技術別分析、細胞内シグナル伝達の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The cell signaling market is expected to reach USD 3.51 billion by 2022 from USD 2.53 billion in 2017, at a CAGR of 6.8%. Factors such as increasing incidence of various chronic diseases; rising funding for cell-based research activities; introduction of innovative and advanced instruments; and growing biotech and biopharmaceutical industries are driving the global cell signaling market.The cell signaling market is categorized based on type, product, technology, pathway, application, and region. The type segment includes endocrine, paracrine, autocrine, juxtacrine, and other types (neuronal and intracrine signaling). The endocrine segment is estimated to account the largest share of the cell...
  • フローサイトメトリーの世界市場予測（～2022年）：技術、製品・サービス、用途、エンドユーザー
    MAM-BT-6015 / MarketsandMarkets / 2018年2月20日 / MarketsandMarketsが発行した当調査レポートでは、フローサイトメトリーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別分析、製品・サービス別分析、需要先別分析、地域別分析、フローサイトメトリーの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global flow cytometry market is projected to grow at a CAGR of 7.8%.”The global flow cytometry market is projected to reach USD 4.79 billion by 2022 from USD 3.29 billion in 2017, growing at a CAGR of 7.8% from 2017 to 2022. The key factors driving the growth of this market include the continuous technological advancements in the field of flow cytometry, increasing incidence and prevalence of target diseases (such as HIV/AIDS and cancer), and growing adoption of flow cytometry in advanced research activities and clinical trials. However, factors such as the high cost of flow cytometry instruments and...
  • 細胞アッセイの世界市場予測（～2022年）：試薬、アッセイキット、マイクロプレート、細胞株、サービス
    MAM-BT2486 / MarketsandMarkets / 2017年7月6日 / 当調査レポートでは、細胞アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、用途別分析、需要先別分析、地域別分析、細胞アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cell-based assays market is expected to reach USD 19.92 Billion by 2022 from USD 13.34 Billion in 2017, at a CAGR of 8.4%. A number of factors, such as growing funding and investments in R&D, the increasing prevalence of chronic disorders, increase in drug discovery activities, and the advantages of cell-based assays over alternative technologies are expected to drive the growth of this market. The global market is segmented by product, application, end user, and region. By product, the global market is segmented into consumables, instruments, service and software. The consumables segment is expected to lead the global...
  • 3D細胞培養の世界市場予測（～2022年）：足場材フリー（懸滴培養、バイオリアクタ）、マイクロ流体力学、磁気浮上
    MAM-BT-4414 / MarketsandMarkets / 2017年11月8日 / MarketsandMarketsが発行した当調査レポートでは、3D細胞培養の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品種類別分析、用途別分析、需要先別分析、地域別分析、3D細胞培養の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global 3D cell culture market is projected to reach USD 1,720.3 Million by 2022 from USD 682.8 Million in 2017, at a CAGR of 20.3%. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness are driving the growth of the market. The report segments the global market into by type of product, application, end user, and region. Based on product, the market is segmented into scaffold-based 3D cell culture, scaffold-free 3D cell culture, microfluidics-based 3D cell culture, and magnetic levitation and...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆